Results 221 to 230 of about 277,876 (250)

Usefulness of TSH receptor antibodies as biomarkers for Graves’ ophthalmopathy: a systematic review

Journal of Endocrinological Investigation, 2018
S. Seo, M. Sánchez Robledo
semanticscholar   +1 more source

Treatment of Graves' ophthalmopathy.

Medicina clínica (Ed. impresa), 2020
A. González-García, M. Sales-Sanz
semanticscholar   +1 more source

Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy

Endocrine Reviews, 2019
Terry J Smith
exaly  

Graves Ophthalmopathy

2015
Maxwell Su, Sumayya J. Almarzouqi, Michael L. Morgan, Andrew G. Lee   +3 more
openaire   +1 more source

Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy

Endocrine Reviews, 2003
Bellur S Prabhakar, Terry J Smith
exaly  

TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy

Nature Reviews Endocrinology, 2015
Terry J Smith
exaly  

Teprotumumab for Thyroid-Associated Ophthalmopathy

New England Journal of Medicine, 2017
Terry J Smith, George J Kahaly, Daniel G Ezra   +2 more
exaly  

Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy

Thyroid, 2017
S. Yu, J. Kang, C. Kim, S. Ihm, M. Choi, H. Yoo, Seong-Jin Lee   +6 more
semanticscholar   +1 more source

Tocilizumab in Graves ophthalmopathy

Medicina Clínica (English Edition), 2020
Gemma, Garreta Fontelles, Cristina, Sangrador Pelluz, Josep Lluis, Macaya Pascual   +2 more
openaire   +2 more sources

Graves’ Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management

Journal of Ophthalmology, 2015
Alfonso L Sabater, Juan C Galofré
exaly